Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Pryat Matharu

  • Home
  • Author: Pryat Matharu

Investors turn to usage-based insurance amid pandemic, says GlobalData

Usage-based insurance (UBI) continues to attract funding despite the fall in insurtech investment due to COVID-19, says GlobalData, a leading data and analytics company. According to GlobalData’s 2019 UK Insurance Consumer Survey, 9.7% of drivers currently have a UBI policy. However, the company expects this figure to increase as a result of COVID-19. UBI operates […]
Read more

Turkish insurance industry to see short-term rise in GWP following COVID-19, says GlobalData

The Turkish insurance market is expected be larger than previously anticipated in 2020 due to product diversification and digitalization following COVID-19, according to GlobalData, a leading data and analytics company. The company’s revised forecasts estimate total gross written premium (GWP) will be ₺68.96bn in 2020, compared to ₺66.07bn previously. However, the revised forecasts see slower […]
Read more

Demand for connected home insurance will fall as consumers stay at home, says GlobalData

COVID-19 will limit the uptake of connected home insurance policies, despite the pandemic making consumers embrace technology, according to GlobalData, a leading data and analytics company. Digitalization is a key trend across all industries, as consumers and businesses avoid face-to-face interactions. However, connected home technology will suffer it is less necessary with people spending significant […]
Read more

Ultrasound systems market to outpace other imaging modalities for COVID-19 diagnostics, says GlobalData

Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market […]
Read more

Zego’s flexible on-demand and telematics-drive fleet policies are ideal for current conditions, says GlobalData

Zego has expanded its fleet partnership with RSA due to the increased demand for deliveries with the company’s on-demand and telematics-drive policies proving to be exactly what customers need during this pandemic, says GlobalData a leading data and analytics company. The Insurance Times stated that the spike in courier fleets and delivery during lockdown has […]
Read more

Insurers’ business interruption U-turn could lead to significant uptake in product, says GlobalData

Following the announcement by the Financial Conduct Authority (FCA) that multiple insurers are to back down on the coronavirus policy dispute and pay company owners with business interruption policies; Ben Carey-Evans, Insurance Analyst at GlobalData, a leading data and analytics company, offers his view: “This is a significant turnaround for the industry, which had up […]
Read more

Swedish banks set for short-term hit but government measures will ensure recovery, says GlobalData

The Swedish Governments’ comprehensive financial packages should ensure its banking sector is relatively insulated from the level of damage felt in other countries, says GlobalData. GlobalData’s expects residential mortgage lending to collapse in Sweden over the next few months. It forecasts negative growth of -1.8% in 2020, compared to 5.2% growth in pre-COVID-19 forecasts. However, […]
Read more

US Army maintaining delivery schedule of new systems amid COVID-19 would be true feat for the service, says GlobalData

Following yesterday’s (27 May 2020) declaration by Bruce Jette, US Army acquisition head, on the delivery schedule of main acquisition programs amid the COVID-19 disruption; Nicolas Jouan, Aerospace & Defense Analyst at GlobalData, a leading data and analytics company, offers his view on the current situation: “At this stage, maintaining the deployment schedule of the […]
Read more

Novavax’ might trail behind Clover’s COVID-19 vaccine due to the latter’s adjuvant choice, while IMV’s vaccine does not have adjuvant boost, says GlobalData

Following the announcement that Novavax has agreed a $167m deal to acquire Praha Vaccines to aid its manufacturing capabilities for its Phase I COVID-19 vaccine candidate; Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, offers his view: “Novavax may be at a disadvantage compared to Clover Biopharmaceuticals, which also has a protein COVID-19 […]
Read more

Prolonged lockdown to push major economies into recession, says GlobalData

Lockdown measures to combat COVID-19 have significantly impacted economic activities worldwide resulting in rampant job losses. Real GDP growth of major economies such as the US, Eurozone, Russia, South Korea and Australia is forecasted to contract sharply in 2020. However, most economies are expected to witness a V-shaped recovery of GDP growth in 2021, says […]
Read more
1 2 3 4 5 6 7